For patients and doctors battling chronic resistant infections, Validus Cellular Therapeutics is developing VCT-101, a novel preclinical stage anti-infective therapy unlike current small molecule antibiotics which are susceptible to resistance and are limited accessing infections. VCT-101 is a cell therapy to be given with standard of care antibiotic regimens to successfully treat of chronic infections through direct bacterial killing and immune system boosting mechanisms.
| Website | http://www.validustherapeutics.com |
| Employees | 3 (1 on RocketReach) |
| Founded | 2019 |
| Address | 12635 E Montview Blvd, Aurora, Colorado 80045, US |
| Phone | +1 720-767-0350 |
| Industry | Pharmaceutical Manufacturing, Telecommunications General, Telecommunications |
| Keywords | Cellular Therapeutics, Preclinical Stage, Drug Development, Cell Therapy, Infection Treatment, Antibiotic Resistance, Biotechnology, Pharmaceutical, Novel Antibiotics, Therapeutics, Immunotherapy, Clinical Trials, Medical Research, Regenerative Medicine |
| Competitors | Johnson & Johnson, Roche, Novartis, Sanofi, AstraZeneca, Bristol Myers Squibb, Amgen, Regeneron, Gilead Sciences, Vertex Pharmaceuticals +46 more (view full list) |
| SIC | SIC Code 481 Companies, SIC Code 48 Companies |
| NAICS | NAICS Code 517312 Companies, NAICS Code 517 Companies, NAICS Code 5173 Companies, NAICS Code 51 Companies, NAICS Code 51731 Companies |
Looking for a particular Validus Cellular Therapeutics employee's phone or email?
Validus Cellular Therapeutics Questions
Dave Desmond is the CFO of Validus Cellular Therapeutics.
1 people are employed at Validus Cellular Therapeutics.
Validus Cellular Therapeutics is based in Aurora, Colorado.
The NAICS codes for Validus Cellular Therapeutics are [517312, 517, 5173, 51, 51731].
The SIC codes for Validus Cellular Therapeutics are [481, 48].
Top Validus Cellular Therapeutics Employees
Related Companies
